Not Yet Recruiting NA INTERVENTIONAL 4-arm
NCT07302880
The Acute Interference of Biotin in Blood Analysis (ABBA)
Sponsor: Bispebjerg Hospital
Interventions
Arm 1 - 10 mg → Placebo Arm 2 - Placebo → 10 mg Arm 3 - 100 mg → Placebo Arm 4 - Placebo → 100 mg Overall: To evaluate the acute effect of biotin intake on streptavidin-based laboratory assays during the hours immediately following consumption
Updated 1 time since 2026 Last updated: Dec 11, 2025 Started: Jan 1, 2026 Primary completion: Mar 1, 2030 Completion: Oct 1, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Biotin Ingestion and Blood Sample, this trial is actively recruiting participants. The trial is conducted by Bispebjerg Hospital and has accumulated 1 data snapshot since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Bispebjerg Hospital
- University of Copenhagen
Data source: University of Copenhagen
For direct contact, visit the study record on ClinicalTrials.gov .